Given that obesity is a major modifiable risk factor for OSAS, and that the pathogenesis of OSAS involves metabolic dysregulation, systemic inflammation, and abnormal adipose tissue distribution, tirzepatide may offer multidimensional therapeutic benefits in this context (26)
They're ideal for pre-diabetes, mild overweight (BMI 27-32), or maintaining results after prescription GLP-1 therapy
This advanced delivery method improves bioavailability and ensures the body receives the full benefit of the copper peptide complex
The gut microbiota is, thus, modifiable as well as a clinically actionable component
Whether used for recovery, gut health, or overall wellness, BPC-157 helps protect and restore the body at a cellular levelsupporting faster healing, improved mobility, and long-term resilience
Before starting treatment, our team conducts a thorough evaluation to ensure these therapies are the perfect fit for your individual needs, setting you on the path to optimized wellness